BIOTRICITY INC (BTCY) Fundamental Analysis & Valuation

NASDAQ:BTCY • US09074H2031

Current stock price

0.4631 USD
-0.18 (-28.31%)
At close:
0.431 USD
-0.03 (-6.93%)
After Hours:

This BTCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BTCY Profitability Analysis

1.1 Basic Checks

  • In the past year BTCY has reported negative net income.
  • In the past year BTCY has reported a negative cash flow from operations.
  • In the past 5 years BTCY always reported negative net income.
  • BTCY had a negative operating cash flow in each of the past 5 years.
BTCY Yearly Net Income VS EBIT VS OCF VS FCFBTCY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -251.17%, BTCY is doing worse than 94.74% of the companies in the same industry.
Industry RankSector Rank
ROA -251.17%
ROE N/A
ROIC N/A
ROA(3y)-244.13%
ROA(5y)-333.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTCY Yearly ROA, ROE, ROICBTCY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

1.3 Margins

  • Looking at the Gross Margin, with a value of 69.32%, BTCY is in the better half of the industry, outperforming 65.79% of the companies in the same industry.
  • BTCY's Gross Margin has improved in the last couple of years.
  • BTCY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.62%
GM growth 5Y13.06%
BTCY Yearly Profit, Operating, Gross MarginsBTCY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BTCY Health Analysis

2.1 Basic Checks

  • BTCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BTCY has been increased compared to 1 year ago.
  • Compared to 5 years ago, BTCY has less shares outstanding
  • The debt/assets ratio for BTCY is higher compared to a year ago.
BTCY Yearly Shares OutstandingBTCY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BTCY Yearly Total Debt VS Total AssetsBTCY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -34.76, we must say that BTCY is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -34.76, BTCY is doing worse than 94.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -34.76
ROIC/WACCN/A
WACC10.46%
BTCY Yearly LT Debt VS Equity VS FCFBTCY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • BTCY has a Current Ratio of 0.20. This is a bad value and indicates that BTCY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BTCY has a Current ratio of 0.20. This is amonst the worse of the industry: BTCY underperforms 92.11% of its industry peers.
  • BTCY has a Quick Ratio of 0.20. This is a bad value and indicates that BTCY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BTCY has a worse Quick ratio (0.11) than 94.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.11
BTCY Yearly Current Assets VS Current LiabilitesBTCY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BTCY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.07% over the past year.
  • BTCY shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.12%.
  • BTCY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 97.64% yearly.
EPS 1Y (TTM)26.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.15%
Revenue 1Y (TTM)25.12%
Revenue growth 3Y52.82%
Revenue growth 5Y97.64%
Sales Q2Q%15.9%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y73.56%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.17%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTCY Yearly Revenue VS EstimatesBTCY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 5M 10M
BTCY Yearly EPS VS EstimatesBTCY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. BTCY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BTCY. In the last year negative earnings were reported.
  • Also next year BTCY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTCY Price Earnings VS Forward Price EarningsBTCY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTCY Per share dataBTCY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BTCY Dividend Analysis

5.1 Amount

  • BTCY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BTCY Fundamentals: All Metrics, Ratios and Statistics

BIOTRICITY INC

NASDAQ:BTCY (8/2/2024, 8:00:02 PM)

After market: 0.431 -0.03 (-6.93%)

0.4631

-0.18 (-28.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)06-27
Earnings (Next)08-12
Inst Owners0.27%
Inst Owner Change0%
Ins Owners25.75%
Ins Owner Change0%
Market Cap9.95M
Revenue(TTM)12.06M
Net Income(TTM)-14.93M
Analysts43.33
Price Target4.08 (781.02%)
Short Float %1.16%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-0.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.63%
Min EPS beat(2)-27.72%
Max EPS beat(2)24.47%
EPS beat(4)2
Avg EPS beat(4)-7.11%
Min EPS beat(4)-27.72%
Max EPS beat(4)24.47%
EPS beat(8)5
Avg EPS beat(8)-4.43%
EPS beat(12)8
Avg EPS beat(12)-3.34%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.74%
Min Revenue beat(2)-2.84%
Max Revenue beat(2)-2.63%
Revenue beat(4)0
Avg Revenue beat(4)-6.02%
Min Revenue beat(4)-14.1%
Max Revenue beat(4)-2.63%
Revenue beat(8)2
Avg Revenue beat(8)-4.5%
Revenue beat(12)4
Avg Revenue beat(12)-3.5%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.66
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.56
BVpS-1.4
TBVpS-1.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -251.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.32%
FCFM N/A
ROA(3y)-244.13%
ROA(5y)-333.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.62%
GM growth 5Y13.06%
F-Score5
Asset Turnover2.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.11
Altman-Z -34.76
F-Score5
WACC10.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.15%
EPS Next Y73.56%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.12%
Revenue growth 3Y52.82%
Revenue growth 5Y97.64%
Sales Q2Q%15.9%
Revenue Next Year19.17%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.6%
OCF growth 3YN/A
OCF growth 5YN/A

BIOTRICITY INC / BTCY Fundamental Analysis FAQ

What is the fundamental rating for BTCY stock?

ChartMill assigns a fundamental rating of 1 / 10 to BTCY.


Can you provide the valuation status for BIOTRICITY INC?

ChartMill assigns a valuation rating of 0 / 10 to BIOTRICITY INC (BTCY). This can be considered as Overvalued.


What is the profitability of BTCY stock?

BIOTRICITY INC (BTCY) has a profitability rating of 1 / 10.


What is the financial health of BIOTRICITY INC (BTCY) stock?

The financial health rating of BIOTRICITY INC (BTCY) is 0 / 10.


Is the dividend of BIOTRICITY INC sustainable?

The dividend rating of BIOTRICITY INC (BTCY) is 0 / 10 and the dividend payout ratio is -0.12%.